Actin' Out, Development of a High Content Screen Protocol for Investigation of the Interplay Between Epithelial Junctions and the Actin Cytoskeleton Dr Ann Wheeler, Queen Mary University of London, speaking at European Laboratory Automation 2012.
Next Generation X-Aptamers for Identification of Personalized Biomarkers in Cancer David G. Gorenstein, Ph.D., University of Texas Health Sciences Center, speaking at Genomics Research 2012.
Genomic and Proteomic Biomarkers for Cardiac and Renal Transplantation: Computational Biomarker Pipeline from Discovery to Clinical Implementation Dr. Robert McMaster, Professor, University of British Columbia, speaking at Genomics Research 2012.
Signalling Molecules as Proteomic Biomarkers in Brain Tumours Radu Albulescu talking on behalf of Cristiana Tanase MD, PhD, Victor Babes University of Medicine and Pharmacy, Timisoara, speaking at Molecular Diagnostics Europe 2012.
Towards a Disease-specific Biomarker Signature for Neuromuscular Disorders Professor Kay Ohlendieck, National University of Ireland, speaking at Molecular Diagnostics Europe 2012.
ESPRIT: High Throughput Screening for Soluble Expression Constructs of Difficult-to-express Proteins Darren Hart, European Molecular Biology Laboratory, speaking at European Lab Automation 2012
Understanding Cell Transitions at Single-Cell Level Dr Anders Ståhlberg, University of Gothenburg in Sweden, speaking at Single Cell Analysis Europe 2012.
Too Big for a Small World? Intact Protein Analysis by Nano-UHPLC-MS/MS Mark Parkin, Kings College London, speaking at European Lab Automation 2012
Capacitive Immunosensors – A Tool for Detection Where Sensitivity of Conventional ELISA is Not Sufficient Prof. Bo Mattiasson, Lund University, speaking at Advances in Biodetection and Biosensors 2012.